A detailed history of Bridgefront Capital, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Bridgefront Capital, LLC holds 6,216 shares of BSX stock, worth $589,774. This represents 0.21% of its overall portfolio holdings.

Number of Shares
6,216
Holding current value
$589,774
% of portfolio
0.21%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.96 - $84.0 $453,519 - $522,144
6,216 New
6,216 $520,000
Q2 2023

Aug 14, 2023

BUY
$49.72 - $54.64 $607,777 - $667,919
12,224 Added 287.08%
16,482 $891,000
Q1 2023

May 15, 2023

SELL
$45.09 - $50.03 $238,571 - $264,708
-5,291 Reduced 55.41%
4,258 $213,000
Q4 2022

Feb 14, 2023

BUY
$39.56 - $47.22 $377,758 - $450,903
9,549 New
9,549 $441,000
Q1 2021

May 17, 2021

SELL
$35.27 - $39.67 $2 Million - $2.25 Million
-56,663 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$33.15 - $41.97 $1.88 Million - $2.38 Million
56,663 New
56,663 $2.04 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $136B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Bridgefront Capital, LLC Portfolio

Follow Bridgefront Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgefront Capital, LLC with notifications on news.